Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanistic Study Using Oral Insulin for Immune Efficacy in Secondary Prevention of Type 1 Diabetes

NCT02620072 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT02620072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02620072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanistic Study Using Oral Insulin for Immune Efficacy in Secondary Prevention of Type 1 Diabetes
Lead sponsor
Technical University of Munich
Phase
Phase 2
Overall status
Completed
Start date
December 11, 2015
Completion date
September 30, 2024
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage 1 diabetes mellitus, type 1